You can now read 10 articles a month for free. Read as much as you want anywhere and anytime for just 99¢.

Red Sox Live

6

2

Final

Market Mover

Pfizer lowers forecast amid sales decline

Rival generics have cut into sales of two-thirds of Pfizer’s drugs. Lipitor sales, for example, are down 55 percent to $626 million.

Associated Press/File 2012

Rival generics have cut into sales of two-thirds of Pfizer’s drugs. Lipitor sales, for example, are down 55 percent to $626 million.

Continue reading below

Pfizer Inc.’s quarterly net income rose 53 percent $2.75 billion, despite falling sales, mainly because the second-largest drug maker took big charges a year ago. The results fell short of expectations, and Pfizer cut its forecasts, blaming currency exchange rates. Overall, revenue was $13.5 billion, down 9 percent from a year earlier. The yearly profit forecast excluding one-time items was cut 6 cents to $2.14 to $2.24 per share.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week